The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: Tenofovir/Emtricitabine     Injury: Foetal exposure during pregnancy     Quarter: 2016Q3

Total Records: 28     Number of Pages: 2

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127784801 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160926 US
127784811 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160926 US
127882441 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160928 US
127882521 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160928 US
127883271 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160928 US
127908441 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160929 US
127908521 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160929 US
127908621 Tenofovir/Emtricitabine Foetal exposure during pregnancy CIPLA 0.00 0 20160929 US

Total Records: 28     Number of Pages: 2